We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma (ADMYRE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01102426
Recruitment Status : Completed
First Posted : April 13, 2010
Last Update Posted : January 4, 2018
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2017
  Study Completion Date : November 2017